{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:57:33Z","timestamp":1789999053533,"version":"4.0.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":2161,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000296","name":"British Skin Foundation","doi-asserted-by":"publisher","award":["S301"],"award-info":[{"award-number":["S301"]}],"id":[{"id":"10.13039\/501100000296","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1038\/jid.2009.207","type":"journal-article","created":{"date-parts":[[2009,7,9]],"date-time":"2009-07-09T08:43:21Z","timestamp":1247129001000},"page":"230-240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Autoantigens in Vitiligo Identified by the Serological Selection of a Phage-Displayed Melanocyte cDNA Expression Library"],"prefix":"10.1016","volume":"130","author":[{"given":"Elizabeth A.","family":"Waterman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Gawkrodger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip F.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony P.","family":"Weetman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Helen Kemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2009.207_bb0010","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1034\/j.1600-0749.2003.00032.x","article-title":"Vitiligo and associated autoimmune diseases in Caucasian probands and their families","volume":"16","author":"Alkhateeb","year":"2003","journal-title":"Pigment Cell Res"},{"key":"10.1038\/jid.2009.207_bb0015","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/rheumatology\/33.10.923","article-title":"Detection of autoantibodies to the 90kDa heat shock protein in systemic lupus erythematosus and other autoimmune diseases","volume":"33","author":"Conroy","year":"1994","journal-title":"Br J Rheumatol"},{"key":"10.1038\/jid.2009.207_bb0020","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0378-1119(93)90253-Y","article-title":"Display of biologically active proteins on the surface of filamentous phages: a cDNA cloning system for selection of functional gene products linked to the genetic information responsible for their production","volume":"137","author":"Crameri","year":"1993","journal-title":"Gene"},{"key":"10.1038\/jid.2009.207_bb0025","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/1523-1747.ep12555773","article-title":"Identification of pigment cell antigens defined by vitiligo antibodies","volume":"98","author":"Cui","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2009.207_bb0030","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1600-0749.2006.00333.x","article-title":"A review and a new hypothesis for non-immunological pathogenetic mechanisms in vitiligo","volume":"19","author":"Dell'Anna","year":"2006","journal-title":"Pigment Cell Res"},{"key":"10.1038\/jid.2009.207_bb0035","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1038\/jid.2008.45","article-title":"HSP70i accelerates depigmentation in a mouse model of autoimmune vitiligo","volume":"128","author":"Denman","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2009.207_bb0040","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0264-410X(99)00204-2","article-title":"Osteopontin is an autoantigen of the somatostatin cells in human islets: identification by screening random peptide libraries with sera of patients with insulin-dependent diabetes mellitus","volume":"18","author":"Fierabracci","year":"1999","journal-title":"Vaccine"},{"key":"10.1038\/jid.2009.207_bb0045","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/rheumatology\/39.10.1114","article-title":"Identification of candidate endothelial cell autoantigens in systemic lupus erythematosus using a molecular cloning strategy: a role for ribosomal P protein as an endothelial cell autoantigen","volume":"39","author":"Frampton","year":"2000","journal-title":"Rheumatol"},{"key":"10.1038\/jid.2009.207_bb0050","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0190-9622(92)70024-A","article-title":"Autologous grafting with non-cultured melanocytes: a simplified method for treatment of depigmented lesions","volume":"26","author":"Gauthier","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/jid.2009.207_bb0055","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.1365-2133.2003.05024.x","article-title":"Melanocyte detachment after skin friction in non lesional skin of patients with generalized vitiligo","volume":"148","author":"Gauthier","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2009.207_bb0060","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/1523-1747.ep12324456","article-title":"In vivo destruction of melanocytes by the IgG fraction of serum from patients with vitiligo","volume":"105","author":"Gilhar","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2009.207_bb0065","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/labinvest.3700438","article-title":"Function blocking autoantibodies to the melanin-concentrating hormone receptor in vitiligo patients","volume":"86","author":"Gottumukkala","year":"2006","journal-title":"Lab Invest"},{"key":"10.1038\/jid.2009.207_bb0070","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1006\/bbrc.1999.1945","article-title":"Identification of tyrosine hydroxylase as an autoantigen in autoimmune polyglandular syndrome type 1","volume":"267","author":"Hedstrand","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/jid.2009.207_bb0075","doi-asserted-by":"crossref","first-page":"35390","DOI":"10.1074\/jbc.M102391200","article-title":"The transcription factors SOX9 and SOX10 are vitiligo autoantigens in autoimmune polyendocrine syndrome type I","volume":"276","author":"Hedstrand","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1038\/jid.2009.207_bb0080","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/1523-1747.ep12276556","article-title":"Detection of tyrosinase autoantibodies in the sera of vitiligo patients using 35S-labelled recombinant human tyrosinase in a radioimmunoassay","volume":"109","author":"Kemp","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2009.207_bb0085","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1365-2249.1997.4781381.x","article-title":"Immunoprecipitation of melanogenic enzyme autoantigens with vitiligo sera: evidence for cross-reactive autoantibodies to tyrosinase and tyrosinase-related protein-2 (TRP-2)","volume":"109","author":"Kemp","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1038\/jid.2009.207_bb0090","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1046\/j.1365-2133.1998.02503.x","article-title":"Autoantibodies to tyrosinase-related protein-1 detected in the sera of vitiligo patients using a quantitative radiobinding assay","volume":"139","author":"Kemp","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2009.207_bb0095","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1365-2249.1998.00746.x","article-title":"Autoantibodies to human melanocyte-specific protein Pmel17 in the sera of vitiligo patients: a sensitive and quantitative radioimmunoassay (RIA)","volume":"114","author":"Kemp","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1038\/jid.2009.207_bb0100","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1046\/j.1365-2249.2001.01516.x","article-title":"Molecular mapping of epitopes on melanocyte-specific protein Pmel17 which are recognised by autoantibodies in patients with vitiligo","volume":"124","author":"Kemp","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"10.1038\/jid.2009.207_bb0105","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1172\/JCI0214643","article-title":"The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo","volume":"109","author":"Kemp","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1038\/jid.2009.207_bb0110","first-page":"7900","article-title":"Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma","volume":"61","author":"Kiniwa","year":"2001","journal-title":"Cancer Res"},{"key":"10.1038\/jid.2009.207_bb0115","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.0022-202X.2005.23653.x","article-title":"4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: relevance to vitiligo","volume":"124","author":"Kroll","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2009.207_bb0120","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1046\/j.1523-1747.2001.01363.x","article-title":"HLA-A2 restricted, melanocyte-specific CD8+ T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA\/MART1","volume":"116","author":"Lang","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2009.207_bb0125","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/archderm.139.5.581","article-title":"A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo","volume":"139","author":"Lepe","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1038\/jid.2009.207_bb0130","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1084\/jem.158.1.246","article-title":"Antibodies to normal human melanocytes in vitiligo","volume":"158","author":"Naughton","year":"1983","journal-title":"J Exp Med"},{"key":"10.1038\/jid.2009.207_bb0135","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/1523-1747.ep12461505","article-title":"Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocyes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity","volume":"90","author":"Norris","year":"1988","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2009.207_bb0140","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.188.6.1203","article-title":"High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo","volume":"188","author":"Ogg","year":"1998","journal-title":"J Exp Med"},{"key":"10.1038\/jid.2009.207_bb0145","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/intimm\/11.10.1635","article-title":"Anti-elongation factor 1 alpha autoantibody in adult atopic dermatitis","volume":"11","author":"Ohkouchi","year":"1999","journal-title":"Int Immunol"},{"key":"10.1038\/jid.2009.207_bb0150","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1046\/j.1523-1747.1998.00411.x","article-title":"Anti-tyrosinase-related protein-2 immune response in vitiligo and melanoma patients receiving active-specific immunotherapy","volume":"111","author":"Okamoto","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2009.207_bb0155","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1046\/j.1523-1747.2001.01408.x","article-title":"Specific cytotoxic T lymphocyte responses against MelanA\/MART1, tyrosinase and Gp100 in vitiligo by the use of major histocompatibility complex\/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo","volume":"117","author":"Palermo","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2009.207_bb0160","first-page":"109","article-title":"Autoantibodies specific for alpha-enolase in systemic autoimmune disorders","volume":"27","author":"Pratesi","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1038\/jid.2009.207_bb0165","first-page":"1492","article-title":"Autoantibodies to osteopontin in patients with osteoarthritis and rheumatoid arthritis","volume":"28","author":"Sakata","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1038\/jid.2009.207_bb0170","series-title":"Molecular cloning: A Laboratory Manual","author":"Sambrook","year":"1989"},{"issue":"Suppl 1","key":"10.1038\/jid.2009.207_bb0175","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.ymgme.2005.07.023","article-title":"Decreased phenylalanine uptake and turnover in patients with vitiligo","volume":"86","author":"Schallreuter","year":"2005","journal-title":"Mol Genet Metab"},{"key":"10.1038\/jid.2009.207_bb0180","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1126\/science.3285470","article-title":"Assembly of a functional immunoglobulin Fv fragment in Escherichia coli","volume":"240","author":"Skerra","year":"1988","journal-title":"Science"},{"key":"10.1038\/jid.2009.207_bb0185","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.4049\/jimmunol.169.5.2772","article-title":"A panel of candidate tumor antigens in colorectal cancer revealed by the serological selection of a phage displayed cDNA expression library","volume":"169","author":"Somers","year":"2002","journal-title":"J Immunol"},{"key":"10.1038\/jid.2009.207_bb0190","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(94)91709-4","article-title":"The role of tyrosinase in autoimmune vitiligo","volume":"344","author":"Song","year":"1994","journal-title":"Lancet"},{"key":"10.1038\/jid.2009.207_bb0195","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1600-0749.2007.00384.x","article-title":"The genetics of generalised vitiligo and associated autoimmune diseases","volume":"20","author":"Spritz","year":"2007","journal-title":"Pigment Cell Res"},{"key":"10.1038\/jid.2009.207_bb0200","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1755-148X.2007.00429.x","article-title":"Transcriptional profiling of melanocytes from patients with vitiligo vulgaris","volume":"21","author":"Stromberg","year":"2007","journal-title":"Pigment Cell Res"},{"key":"10.1038\/jid.2009.207_bb0205","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1365-2265.2006.02661.x","article-title":"Alpha-enolase: a novel autoantigen in patients with premature ovarian failure","volume":"65","author":"Sundblad","year":"2006","journal-title":"Clin Endocrinol"},{"issue":"Supplement 8","key":"10.1038\/jid.2009.207_bb0210","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1034\/j.1600-0749.13.s8.9.x","article-title":"Intrinsic and extrinsic pathomechanisms in vitiligo","volume":"13","author":"Taieb","year":"2000","journal-title":"Pigment Cell Res"},{"key":"10.1038\/jid.2009.207_bb0215","series-title":"J Invest Dermatol","article-title":"Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients","author":"Van den Boorn","year":"2009"},{"key":"10.1038\/jid.2009.207_bb0220","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/ng0796-366","article-title":"Epithelial detachment due to absence of hemidesmosomes in integrin beta 4 null mice","volume":"13","author":"Van der Neut","year":"1996","journal-title":"Nat Genet"},{"key":"10.1038\/jid.2009.207_bb0225","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1083\/jcb.200606050","article-title":"Rab38 and Rab32 control post-Golgi trafficking of melanogenic enzymes","volume":"175","author":"Wasmeier","year":"2006","journal-title":"J Cell Biol"},{"key":"10.1038\/jid.2009.207_bb0230","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1006\/excr.2000.4803","article-title":"Regulation of microphthalmia-associated transcription factor MITF protein levels by association with the ubiquitin-conjugating enzyme hUBC9","volume":"255","author":"Xu","year":"2000","journal-title":"Exp Cell Res"},{"key":"10.1038\/jid.2009.207_bb0235","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00262-006-0177-z","article-title":"Melanocyte differentiation antigen RAB38\/NY-MEL-1 induces frequent antibody responses exclusively in melanoma patients","volume":"56","author":"Zippelius","year":"2007","journal-title":"Cancer Immunol Immunother"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15345462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15345462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T17:17:50Z","timestamp":1743959870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15345462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0022202X15345462"],"URL":"https:\/\/doi.org\/10.1038\/jid.2009.207","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantigens in Vitiligo Identified by the Serological Selection of a Phage-Displayed Melanocyte cDNA Expression Library","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/jid.2009.207","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}